The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era

Since the late 1990s, tumor necrosis factor alpha (TNF-α) inhibitors (anti-TNFs) have revolutionized the therapy of immune-mediated inflammatory diseases (IMIDs) affecting the gut, joints, skin and eyes. Although the therapeutic armamentarium in IMIDs is being constantly expanded, anti-TNFs remain t...

Descripción completa

Detalles Bibliográficos
Autores principales: Evangelatos, Gerasimos, Bamias, Giorgos, Kitas, George D., Kollias, George, Sfikakis, Petros P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063259/
https://www.ncbi.nlm.nih.gov/pubmed/35503130
http://dx.doi.org/10.1007/s00296-022-05136-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063259/
https://www.ncbi.nlm.nih.gov/pubmed/35503130
http://dx.doi.org/10.1007/s00296-022-05136-x

Ejemplares similares